Skip to main content
. 2024 Sep 19;13(9):513–524. doi: 10.1302/2046-3758.139.BJR-2024-0109

Fig. 4.

Fig. 4

Findings from surveys when respondents were asked about how acceptable they believed testing agents in human experimental medicine studies in scenarios a, b, and c to be. Survey findings for: a) healthcare professionals, clinicians, and/or researchers (HCP/Rs) from Survey 1; and b) people with joint damage caused by knee injury and/or osteoarthritis (PJDs) from Survey 2. The six Likert scale options are listed in the key.